Gonadal hormone deprivation regulates response to tibolone in neurodegenerative pathways

Andrew J McGovern1, Maria Angeles Arevalo2, Sergio Ciordia3

  • 1Department of Biological Sciences, Faculty of Science and Engineering, University of Limerick, Limerick, Ireland.

Insights

Gonadal hormone deprivation impacts brain molecular environment, altering hormone therapy (HT) effectiveness. This study reveals Tibolone

Area of Science:

  • Neuroendocrinology
  • Molecular Neuroscience
  • Proteomics

Background:

  • Gonadal hormone deprivation (GHD) increases neurodegeneration risk.
  • Hormone therapies (HTs) have variable efficacy, influenced by sex, drug, and timing.
  • Brain molecular environment changes post-GHD, affecting HT response.

Purpose of the Study:

  • Investigate the impact of GHD on the brain's molecular response to Tibolone.
  • Identify molecular mechanisms underlying variable HT efficacy.
  • Explore precision medicine approaches for HTs in neurodegeneration.

Main Methods:

  • Utilized a mouse model of GHD treated with Tibolone.
  • Performed proteomic analysis to identify protein changes.
  • Employed network pharmacology to analyze pathway interactions.

Main Results:

  • Identified a reprogrammed Tibolone response in the GHD brain.
  • Discovered altered responses in neurodegeneration, cellular respiration, and homeostasis pathways.
  • Found 23 proteins with GHD/sex-dependent Tibolone responses, affecting oxidative phosphorylation and calcium signaling.

Conclusions:

  • Therapeutic efficacy of HTs is contingent on GHD and sex.
  • Precision medicine is crucial for optimizing HTs.
  • Further research is needed to elucidate underlying mechanisms of variable HT response.

Related Concept Videos

Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
476